Last Updated:
Name Designation Appointment Date Status
Venkatram Reddy Pulagam

Appointed as Director since August 2011

 Director 01-Aug-2011 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Innomorph Drugs Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Veera Venkata Siva Kumar Reddy Bommareddy

Appointed as Director since November 2004

 Director 11-Nov-2004 Current
Pavani Bommareddy

Appointed as Director since November 2004

 Director 11-Nov-2004 Current

People Timeline

Explore the timeline of key personnel in Innomorph Drugs Private Limited's leadership journey.

Contact Details
  • Address 6-3-883/5. Venkat Plaza.Punjagutta, Hyderabad,082 Punjagutta, Hyderabad,082, Punjagutta, Hyderabad,082 Telangana, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code
  • Country India
  • Website -
Frequently Asked Questions
You can contact Innomorph Drugs Private Limited through their registered address at 6-3-883/5. Venkat Plaza.Punjagutta, Hyderabad,082 Punjagutta, Hyderabad,082, Punjagutta, Hyderabad,082 Telangana, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Innomorph Drugs Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • PAVANI BOMMAREDDY
  • VENKATRAM REDDY PULAGAM
  • VEERA VENKATA SIVA KUMAR REDDY BOMMAREDDY
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available